Difference between revisions of "Part:BBa K5237007"
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K5237007</partinfo> | <partinfo>BBa_K5237007</partinfo> | ||
Line 25: | Line 24: | ||
border: 0.5px solid black; | border: 0.5px solid black; | ||
border-collapse: collapse; | border-collapse: collapse; | ||
+ | padding: 5px; | ||
} | } | ||
− | + | .thumbcaption { | |
− | + | text-align: justify !important; | |
− | padding: | + | } |
+ | |||
+ | |||
+ | a[href ^="https://"], | ||
+ | .link-https { | ||
+ | background: none !important; | ||
+ | padding-right: 0px !important; | ||
} | } | ||
</style> | </style> | ||
Line 37: | Line 43: | ||
<section id="1"> | <section id="1"> | ||
<h1>Staple subunit: GCN4</h1> | <h1>Staple subunit: GCN4</h1> | ||
− | <p>GCN4 is a yeast transcription factor belonging to the bZip family of DNA-binding proteins. | + | <p>GCN4 is a yeast transcription factor belonging to the bZip family of DNA-binding proteins. |
− | We use GCN4 to study DNA-binding kinetics in our "Mini staples" that bring two DNA target sites into proximity by binding them simultaneously. | + | We use GCN4 to study DNA-binding kinetics in our "Mini staples" that bring two DNA target sites into proximity by |
− | + | binding them simultaneously. | |
− | <p> | + | </p> |
+ | <p> </p> | ||
</section> | </section> | ||
− | <div | + | <div class="toc" id="toc"> |
<div id="toctitle"> | <div id="toctitle"> | ||
<h1>Contents</h1> | <h1>Contents</h1> | ||
Line 58: | Line 65: | ||
<li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span | <li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span | ||
class="toctext">Results</span></a> | class="toctext">Results</span></a> | ||
− | + | <ul> | |
− | + | <li class="toclevel-2 tocsection-6"><a href="#4.1"><span class="tocnumber">4.1</span> <span class="toctext">Protein expression and | |
− | + | purification</span></a> | |
− | + | </li> | |
− | + | <li class="toclevel-2 tocsection-7"><a href="#4.2"><span class="tocnumber">4.2</span> <span class="toctext">Electrophoretic Mobility | |
− | + | shift assay</span></a> | |
+ | </li> | ||
+ | <li class="toclevel-2 tocsection-8"><a href="#4.3"><span class="tocnumber">4.3</span> <span class="toctext"><i>In Silico</i> | ||
+ | Characterization using DaVinci</span></a> | ||
+ | </ul> | ||
</li> | </li> | ||
<li class="toclevel-1 tocsection-8"><a href="#5"><span class="tocnumber">5</span> <span | <li class="toclevel-1 tocsection-8"><a href="#5"><span class="tocnumber">5</span> <span | ||
Line 71: | Line 82: | ||
</div> | </div> | ||
<section> | <section> | ||
+ | <p><br /><br /></p> | ||
<font size="5"><b>The PICasSO Toolbox </b> </font> | <font size="5"><b>The PICasSO Toolbox </b> </font> | ||
− | + | <div class="thumb" style="margin-top:10px;"></div> | |
− | <div class="thumb"></div> | + | <div class="thumbinner" style="width:550px"><img alt="" class="thumbimage" |
− | + | src="https://static.igem.wiki/teams/5237/wetlab-results/registry-part-collection-engineering-cycle-example-overview.svg" | |
− | + | style="width:99%;" /> | |
− | + | <div class="thumbcaption"> | |
− | + | <i><b>Figure 1: How our part collection can be used to engineer new staples</b></i> | |
</div> | </div> | ||
</div> | </div> | ||
− | |||
<p> | <p> | ||
− | <br> | + | <br /> |
− | + | Next to the well-studied linear DNA sequence, the 3D spatial organization of DNA plays a crucial role in gene | |
− | + | regulation, | |
− | + | cell fate, disease development and more. However, the tools to precisely manipulate this genomic architecture | |
− | + | remain limited, rendering it challenging to explore the full potential of the | |
3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular | 3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular | ||
toolbox based on various DNA-binding proteins to address this issue. | toolbox based on various DNA-binding proteins to address this issue. | ||
− | |||
</p> | </p> | ||
<p> | <p> | ||
Line 99: | Line 109: | ||
Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and | Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and | ||
testing of new staples, ensuring functionality <i>in vitro</i> and <i>in vivo</i>. We took special care to include | testing of new staples, ensuring functionality <i>in vitro</i> and <i>in vivo</i>. We took special care to include | ||
− | parts crucial for testing every step of the cycle (design, build, test, learn) when engineering new parts | + | parts crucial for testing every step of the cycle (design, build, test, learn) when engineering new parts. |
</p> | </p> | ||
− | + | <p>At its heart, the PICasSO part collection consists of three categories. <br /><b>(i)</b> Our <b>DNA-binding | |
− | <p>At its heart, the PICasSO part collection consists of three categories. <br><b>(i)</b> Our <b>DNA-binding proteins</b> | + | proteins</b> |
include our | include our | ||
finalized enhancer hijacking Cas staple as well as half staples that can be used by scientists to compose entirely | finalized enhancer hijacking Cas staple as well as half staples that can be used by scientists to compose entirely | ||
− | new Cas staples in the future. We also include our | + | new Cas staples in the future. We also include our Simple staples that serve as controls for successful stapling |
− | and can be further engineered to create alternative, simpler and more compact staples. <br> | + | and can be further engineered to create alternative, simpler and more compact staples. <br /> |
− | <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance the functionality of our Cas and Basic staples. These | + | <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance the functionality of our Cas and |
+ | Basic staples. These | ||
consist of | consist of | ||
protease-cleavable peptide linkers and inteins that allow condition-specific, dynamic stapling <i>in vivo</i>. | protease-cleavable peptide linkers and inteins that allow condition-specific, dynamic stapling <i>in vivo</i>. | ||
− | Besides staple functionality, we also include the parts to enable the efficient delivery of PICasSO's constructs with our | + | Besides staple functionality, we also include the parts to enable the efficient delivery of PICasSO's constructs |
− | interkingdom conjugation system. <br> | + | with our |
− | <b>(iii)</b> As the final | + | interkingdom conjugation system. <br /> |
+ | <b>(iii)</b> As the final category of our collection, we provide parts that support the use of our <b>custom | ||
+ | readout | ||
systems</b>. These include components of our established FRET-based proximity assay system, enabling users to | systems</b>. These include components of our established FRET-based proximity assay system, enabling users to | ||
confirm | confirm | ||
accurate stapling. Additionally, we offer a complementary, application-oriented testing system for functional | accurate stapling. Additionally, we offer a complementary, application-oriented testing system for functional | ||
− | + | readouts via a luciferase reporter, which allows for straightforward experimental simulation of enhancer hijacking | |
+ | in mammalian cells. | ||
</p> | </p> | ||
<p> | <p> | ||
− | The following table gives a | + | The following table gives a comprehensive overview of all parts in our PICasSO toolbox. <mark |
− | + | style="background-color: #FFD700; color: black;">The highlighted parts showed | |
+ | exceptional performance as described on our iGEM wiki and can serve as a reference.</mark> The other parts in | ||
+ | the | ||
collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their | collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their | ||
− | own custom Cas staples, enabling further optimization and innovation.<br> | + | own custom Cas staples, enabling further optimization and innovation.<br /> |
</p> | </p> | ||
<p> | <p> | ||
− | <font size="4"><b>Our part collection includes:</b></font><br> | + | <font size="4"><b>Our part collection includes:</b></font><br /> |
</p> | </p> | ||
− | + | <table style="width: 90%; padding-right:10px;"> | |
− | <table style="width: 90%;"> | + | <td align="left" colspan="3"><b>DNA-binding proteins: </b> |
− | <td | + | |
The building blocks for engineering of custom staples for DNA-DNA interactions with a modular system ensuring | The building blocks for engineering of custom staples for DNA-DNA interactions with a modular system ensuring | ||
easy assembly.</td> | easy assembly.</td> | ||
Line 135: | Line 150: | ||
<tr bgcolor="#FFD700"> | <tr bgcolor="#FFD700"> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td> | ||
− | <td>fgRNA | + | <td>fgRNA Entry vector MbCas12a-SpCas9</td> |
<td>Entryvector for simple fgRNA cloning via SapI</td> | <td>Entryvector for simple fgRNA cloning via SapI</td> | ||
</tr> | </tr> | ||
− | <tr> | + | <tr bgcolor="#FFD700"> |
<td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td> | ||
<td>Staple subunit: dMbCas12a-Nucleoplasmin NLS</td> | <td>Staple subunit: dMbCas12a-Nucleoplasmin NLS</td> | ||
− | <td>Staple subunit that can be combined to form a functional staple | + | <td>Staple subunit that can be combined with sgRNA or fgRNA and dCas9 to form a functional staple</td> |
</tr> | </tr> | ||
− | <tr> | + | <tr bgcolor="#FFD700"> |
<td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td> | ||
<td>Staple subunit: SV40 NLS-dSpCas9-SV40 NLS</td> | <td>Staple subunit: SV40 NLS-dSpCas9-SV40 NLS</td> | ||
− | <td>Staple subunit that can be combined | + | <td>Staple subunit that can be combined witha sgRNA or fgRNA and dCas12avto form a functional staple |
</td> | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td> | ||
− | <td>Cas | + | <td>Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS</td> |
− | <td>Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands | + | <td>Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands into close |
+ | proximity | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 158: | Line 174: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td> | ||
<td>Staple subunit: Oct1-DBD</td> | <td>Staple subunit: Oct1-DBD</td> | ||
− | <td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br> | + | <td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br /> |
Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | ||
</tr> | </tr> | ||
Line 164: | Line 180: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td> | ||
<td>Staple subunit: TetR</td> | <td>Staple subunit: TetR</td> | ||
− | <td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br> | + | <td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br /> |
Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td> | ||
− | <td>Simple | + | <td>Simple staple: TetR-Oct1</td> |
<td>Functional staple that can be used to bring two DNA strands in close proximity</td> | <td>Functional staple that can be used to bring two DNA strands in close proximity</td> | ||
</tr> | </tr> | ||
Line 189: | Line 205: | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
− | <td | + | <td align="left" colspan="3"><b>Functional elements: </b> |
− | Protease cleavable peptide linkers and inteins are used to control and modify staples for further optimization | + | Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization |
− | for custom applications | + | for custom applications</td> |
<tbody> | <tbody> | ||
<tr bgcolor="#FFD700"> | <tr bgcolor="#FFD700"> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td> | ||
− | <td>Cathepsin B- | + | <td>Cathepsin B-cleavable Linker: GFLG</td> |
− | <td>Cathepsin B cleavable peptide linker | + | <td>Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive |
staples</td> | staples</td> | ||
</tr> | </tr> | ||
Line 202: | Line 218: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td> | ||
<td>Cathepsin B Expression Cassette</td> | <td>Cathepsin B Expression Cassette</td> | ||
− | <td> | + | <td>Expression Cassette for the overexpression of cathepsin B</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td> | ||
<td>Caged NpuN Intein</td> | <td>Caged NpuN Intein</td> | ||
− | <td> | + | <td>A caged NpuN split intein fragment that undergoes protein <i>trans</i>-splicing after protease activation. |
+ | Can be used to create functionalized staples | ||
units</td> | units</td> | ||
</tr> | </tr> | ||
Line 213: | Line 230: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td> | ||
<td>Caged NpuC Intein</td> | <td>Caged NpuC Intein</td> | ||
− | <td> | + | <td>A caged NpuC split intein fragment that undergoes protein <i>trans</i>-splicing after protease activation. |
+ | Can be used to create functionalized staples | ||
units</td> | units</td> | ||
</tr> | </tr> | ||
Line 219: | Line 237: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td> | ||
<td>fgRNA processing casette</td> | <td>fgRNA processing casette</td> | ||
− | <td>Processing casette to produce multiple fgRNAs from one transcript, can be used for | + | <td>Processing casette to produce multiple fgRNAs from one transcript, that can be used for multiplexed 3D |
+ | genome reprograming</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 226: | Line 245: | ||
<td>Interkindom conjugation between bacteria and mammalian cells, as alternative delivery tool for large | <td>Interkindom conjugation between bacteria and mammalian cells, as alternative delivery tool for large | ||
constructs</td> | constructs</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><a href="https://parts.igem.org/Part:BBa_K4643003" target="_blank">BBa_K4643003</a></td> | ||
+ | <td>incP origin of transfer</td> | ||
+ | <td>Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a means of | ||
+ | delivery</td> | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
− | <td | + | <td align="left" colspan="3"><b>Readout Systems: </b> |
FRET and enhancer recruitment to measure proximity of stapled DNA in bacterial and mammalian living cells | FRET and enhancer recruitment to measure proximity of stapled DNA in bacterial and mammalian living cells | ||
− | enabling swift testing and easy development for new systems | + | enabling swift testing and easy development for new systems</td> |
<tbody> | <tbody> | ||
<tr bgcolor="#FFD700"> | <tr bgcolor="#FFD700"> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td> | ||
<td>FRET-Donor: mNeonGreen-Oct1</td> | <td>FRET-Donor: mNeonGreen-Oct1</td> | ||
− | <td> | + | <td>FRET Donor-Fluorpohore fused to Oct1-DBD that binds to the Oct1 binding cassette. Can be used to visualize |
+ | DNA-DNA | ||
proximity</td> | proximity</td> | ||
</tr> | </tr> | ||
Line 247: | Line 273: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237018" target="_blank">BBa_K5237018</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237018" target="_blank">BBa_K5237018</a></td> | ||
<td>Oct1 Binding Casette</td> | <td>Oct1 Binding Casette</td> | ||
− | <td>DNA sequence containing 12 Oct1 binding motifs, | + | <td>DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET |
proximity assay</td> | proximity assay</td> | ||
</tr> | </tr> | ||
Line 258: | Line 284: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td> | ||
<td>Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64</td> | <td>Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64</td> | ||
− | <td>Readout system that responds to protease activity. It was used to test | + | <td>Readout system that responds to protease activity. It was used to test cathepsin B-cleavable linker</td> |
− | + | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td> | ||
<td>NLS-Gal4-VP64</td> | <td>NLS-Gal4-VP64</td> | ||
− | <td>Trans-activating enhancer, that can be used to simulate enhancer hijacking | + | <td>Trans-activating enhancer, that can be used to simulate enhancer hijacking</td> |
</tr> | </tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td> | ||
<td>mCherry Expression Cassette: UAS, minimal Promotor, mCherry</td> | <td>mCherry Expression Cassette: UAS, minimal Promotor, mCherry</td> | ||
− | <td>Readout system for enhancer binding. It was used to test | + | <td>Readout system for enhancer binding. It was used to test cathepsin B-cleavable linker</td> |
− | + | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td> | ||
<td>Oct1 - 5x UAS binding casette</td> | <td>Oct1 - 5x UAS binding casette</td> | ||
− | <td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay | + | <td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 278: | Line 304: | ||
<td>TRE-minimal promoter- firefly luciferase</td> | <td>TRE-minimal promoter- firefly luciferase</td> | ||
<td>Contains Firefly luciferase controlled by a minimal promoter. It was used as a luminescence readout for | <td>Contains Firefly luciferase controlled by a minimal promoter. It was used as a luminescence readout for | ||
− | simulated enhancer hijacking | + | simulated enhancer hijacking</td> |
</tr> | </tr> | ||
</tbody> | </tbody> | ||
</table> | </table> | ||
− | |||
</section> | </section> | ||
<section id="1"> | <section id="1"> | ||
Line 288: | Line 313: | ||
</section> | </section> | ||
</body> | </body> | ||
− | |||
+ | </html> | ||
<!--################################--> | <!--################################--> | ||
− | <span class= | + | <span class="h3bb">Sequence and Features</span> |
<partinfo>BBa_K5237007 SequenceAndFeatures</partinfo> | <partinfo>BBa_K5237007 SequenceAndFeatures</partinfo> | ||
<!--################################--> | <!--################################--> | ||
− | |||
<html> | <html> | ||
− | |||
− | |||
<section id="2"> | <section id="2"> | ||
− | + | <h1>2. Usage and Biology</h1> | |
− | + | <p> | |
− | + | GCN4 is a yeast transcription factor from the bZip family of DNA-binding proteins, first discovered by McKnight and | |
− | + | co-workers in 1988. | |
− | + | The bZip motif features a coiled-coil leucine zipper dimerization domain paired with a highly charged basic region, | |
− | + | which directly interacts | |
+ | with DNA. GCN4 binds specifically to the cyclic AMP response element (CRE) DNA sequence (5' ATGACGTCAT 3') in the | ||
+ | promoter regions of target genes, primarily through its basic | ||
+ | residues at the N-terminus. | ||
+ | </p> | ||
+ | <p> | ||
+ | In our project, GCN4 was employed to study DNA-binding kinetics and develop a minimal "Mini staple" that brings two | ||
+ | DNA target sites into proximity | ||
+ | by binding them simultaneously. This "Mini staple" was designed as a versatile tool for precise DNA manipulation in | ||
+ | synthetic biology applications. | ||
+ | </p> | ||
+ | <p> | ||
+ | The DNA-binding properties of GCN4 were tested using an electrophoretic mobility shift assay (EMSA) to quantify | ||
+ | binding affinity and kinetics. | ||
+ | EMSA is a widely adopted method to study DNA-protein interactions. It works on the principle that nucleic acids | ||
+ | bound to proteins exhibit reduced | ||
+ | electrophoretic mobility compared to unbound nucleic acids (Hellman & Fried, 2007). EMSA can be employed both | ||
+ | qualitatively, to assess DNA-binding | ||
+ | capabilities, and quantitatively, to determine critical parameters such as binding stoichiometry and the apparent | ||
+ | dissociation constant (K<sub>d</sub>) | ||
+ | (Fried, 1989). | ||
+ | </p> | ||
+ | </section> | ||
+ | <section id="3"> | ||
+ | <h1>3. Assembly and part evolution</h1> | ||
+ | <p> | ||
+ | The GCN4 amino acid sequence was taken from literature (Hollenbeck et al. 2001) and codon optimized for <i>E. | ||
+ | coli</i>. | ||
+ | A FLAG-tag (DYKDDDDK) was added to the N-terminus for protein purification. The FLAG-tag can be cleaved off using an | ||
+ | Enterokinase, if necessary. | ||
+ | The FLAG-GCN4 sequence was cloned into a T7 expression vector and expressed using <i>E. coli</i> BL21 (DE3) cells. | ||
+ | </p> | ||
+ | </section> | ||
+ | <section id="4"> | ||
+ | <h1>4. Results</h1> | ||
+ | <section id="4.1"> | ||
+ | <h2>4.1 Protein expression and purification</h2> | ||
+ | <p>The FLAG-GCN4 protein could be readily expressed in <i>E. coli</i> BL21 (DE3). The protein was purified using an | ||
+ | anti-FLAG resin. | ||
+ | Fractions taken during purification were analyzed by SDS-PAGE. Purified protein was quantified using a Lowry | ||
+ | assay, 1.18 mg/mL were obtained, resulting in 153 µM of monomeric FLAG-GCN4. | ||
</p> | </p> | ||
− | + | <div class="thumb"> | |
− | + | <div class="thumbinner" style="width:500px"> | |
− | + | <img alt="" class="thumbimage" | |
− | + | src="https://static.igem.wiki/teams/5237/wetlab-results/mist-sds-page-expression-validation.svg" | |
− | + | style="width:99%;" /> | |
− | + | <div class="thumbcaption"> | |
− | + | <i><b>Figure 2: SDS-PAGE analysis of FLAG-GCN4 purification</b> Fractions analysed are the raw lysate, flow | |
− | + | through and eluate. | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
Depicted is GCN4 (this part), rGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237008" | Depicted is GCN4 (this part), rGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237008" | ||
target="_blank">BBa_K5237008</a>), and bGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237009" | target="_blank">BBa_K5237008</a>), and bGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237009" | ||
− | target="_blank">BBa_K5237009</a>) | + | target="_blank">BBa_K5237009</a>). Protein size is indicated next to construct name and purified band |
− | + | with protein of interest highlighted by a red box.</i> | |
− | + | ||
</div> | </div> | ||
</div> | </div> | ||
− | </section> | + | </div> |
− | + | </section> | |
− | + | <section id="4.2"> | |
− | + | <h2>4.2 Electrophoretic Mobility shift assay</h2> | |
− | + | ||
− | + | <div class="thumb tright"> | |
− | + | <div class="thumbinner" style="width:310px;"> | |
− | + | <img alt="" class="thumbimage" | |
− | + | src="https://static.igem.wiki/teams/5237/figures-corrected/leucin-zipper-emsa.svg" style="width:99%;" /> | |
− | + | <div class="thumbcaption"> | |
− | + | <i> | |
− | + | <b>Figure 3: Overview Image of Electrophoretic Mobility Shift Assay (EMSA)</b> | |
− | + | </i> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
</div> | </div> | ||
− | + | </div> | |
− | + | <p align="justify"></p> | |
− | + | The Electrophoretic mobility shift assay (EMSA) is a widely adopted method used to study DNA-protein | |
− | + | interactions. EMSA functions on the basis that nucleic acids bound to proteins have reduced electrophoretic | |
− | + | mobility, compared to their counterpart. (Hellman & Fried, 2007). Mobility-shift | |
− | + | assays can both be used to qualitatively assess DNA binding capabilities or quantitatively to determine binding | |
− | + | stoichiometry and kinetics such as the apparent dissociation constant (K<sub>d</sub>) (Fried, 1989). | |
− | + | </p> | |
− | + | <p> | |
− | + | GCN4 was tested for its DNA-binding capabilities using an electrophoretic mobility shift assay (EMSA). The protein | |
− | + | was incubated with a DNA probe containing the GCN4 binding site. The formation of a protein-DNA complex was | |
− | + | analyzed by native PAGE. | |
− | + | To further analyze DNA binding, quantitative shift assays were performed for GCN4 and rGCN4 (<a | |
− | + | href="https://parts.igem.org/Part:BBa:K5237008">BBa_K5237008</a>). | |
− | + | 0.5 µM DNA were incubated with varying concentrations of protein until equilibration. After | |
− | + | electrophoresis, bands were stained with SYBR-Safe and quantified based on pixel intensity. The | |
− | + | obtained values were fitted to equation 1, describing formation of a 2:1 protein-DNA complex: | |
− | + | <br /><br /> | |
− | + | Θ<sub>app</sub> = Θ<sub>min</sub> + (Θ<sub>max</sub> - Θ<sub>min</sub>) × | |
− | + | (K<sub>a</sub><sup>2</sup> [L]<sub>tot</sub><sup>2</sup>) / (1 + K<sub>a</sub><sup>2</sup> | |
− | + | [L]<sub>tot</sub><sup>2</sup>) | |
− | + | <span style="float: right;">Equation 1</span> | |
− | + | <br /><br /> | |
− | + | Here [L]<sub>tot</sub> describes the total protein monomer concentration, K<sub>a</sub> | |
− | + | corresponds | |
− | + | to the apparent monomeric equilibration constant. The Θ<sub>min/max</sub> values are the | |
− | + | experimentally | |
− | + | determined site saturation values (For this experiment 0 and 1 were chosen for min and max | |
− | + | respectively). GCN4 binds to its optimal DNA binding motif with an apparent dissociation | |
− | + | constant K<sub>k</sub> of (0.2930.033)×10<sup>-6</sup> M, which is almost identical to the | |
− | + | rGCN4 binding | |
+ | affinity to INVii a <sub>d</sub> of (0.2980.030)×10<sup>-6</sup> M. | ||
+ | </p> | ||
+ | <div class="thumb"> | ||
+ | <div class="thumbinner" style="width:500px"> | ||
+ | <img alt="" class="thumbimage" | ||
+ | src="https://static.igem.wiki/teams/5237/wetlab-results/mist-leucine-zipper-kd-plot.svg" style="width:99%;" /> | ||
+ | <div class="thumbcaption"> | ||
+ | <i><b>Figure 4: Quantitative EMSA</b>Quantitative assessment of binding affinity for GCN4 and rGCN4. Proteins | ||
+ | of | ||
+ | different concentrations were incubated with 0.5 µM DNA until equilibrium and fraction bound analyzed, after | ||
+ | gel electrophoresis, by dividing pixel intensity of | ||
+ | bound fraction with pixel intensity of bound and unbound fraction. At least three separate measurements were | ||
+ | conducted | ||
+ | for each data point. Values are presented as mean +/- SD.</i> | ||
+ | </div> | ||
</div> | </div> | ||
<p> | <p> | ||
− | The apparent binding kinetics calculated for GCN4 ((0.2930.033) | + | The apparent binding kinetics calculated for GCN4 ((0.2930.033) × 10<sup>-6</sup> M) and rGCN4 |
− | ((0.2980.030) | + | ((0.2980.030) × 10<sup>-6</sup> M) are |
− | approximately a factor 10 higher then those described in literature ((96) | + | approximately a factor 10 higher then those described in literature ((96) × 10<sup>-8</sup> M for |
− | GCN4 and (2.90.8) | + | GCN4 and (2.90.8) × 10<sup>-8</sup> M for rGCN4) (Hollenbeck <i class="italic">et al.</i>, 2001). The |
differences could be due to the lower sensitivity of SYBR-Safe staining compared to radio-labeled oligos. | differences could be due to the lower sensitivity of SYBR-Safe staining compared to radio-labeled oligos. | ||
− | Most likely, the protein concentration was miscalculated due to the presence of additional (lower intensity) bands in | + | Most likely, the protein concentration was miscalculated due to the presence of additional (lower intensity) |
+ | bands in | ||
the SDS-PAGE analysis, indicating the co-purification of small amounts of unspecific proteins. | the SDS-PAGE analysis, indicating the co-purification of small amounts of unspecific proteins. | ||
− | <br><br> | + | <br /><br /> |
The FLAG-tag fusion to the N-terminus of proteins could potentially decrease binding affinity, likely due | The FLAG-tag fusion to the N-terminus of proteins could potentially decrease binding affinity, likely due | ||
to steric hindrance affecting the interaction with DNA. Interestingly, the differences in binding affinity | to steric hindrance affecting the interaction with DNA. Interestingly, the differences in binding affinity | ||
Line 414: | Line 461: | ||
FLAG-tag can be cleaved using an enterokinase and potential changes in binding affinity analyzed | FLAG-tag can be cleaved using an enterokinase and potential changes in binding affinity analyzed | ||
</p> | </p> | ||
+ | </div> | ||
</section> | </section> | ||
− | <section | + | <section> |
− | < | + | <h2>4.3 <i>In Silico</i> Characterization using DaVinci</h2> |
− | <p> | + | <p> |
− | + | We developed the in silico model <a href="https://2024.igem.wiki/heidelberg/model" target="_blank">DaVinci</a> | |
− | + | for rapid engineering | |
− | <p> | + | and development of our PiCasSO system. |
− | + | DaVinci acts as a digital twin to PiCasSO, designed to understand the forces acting on our system, | |
− | < | + | refine experimental parameters, and find optimal connections between protein staples and target DNA. |
− | + | We calibrated DaVinci with literature and our own experimental affinity data obtained via EMSA assays and | |
+ | purified | ||
+ | proteins. This enabled us to simulate enhancer hijacking in silico, providing valuable input for the design of | ||
+ | further | ||
+ | experiments. Additionally, we apply the same approach to our part collection. | ||
+ | DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged | ||
+ | dna | ||
+ | dynamics simulation. We applied the first two to our parts, characterizing structure and dynamics of the | ||
+ | dna-binding | ||
+ | interaction. | ||
+ | </p> | ||
+ | <p> | ||
+ | In our efforts to create a bivalent DNA binding protein with minimal size, we designed a Mini staple consisting of | ||
+ | GCN4 fused with an GSG-linker to rGCN4. The structure and binding affinity of GCN4 were predicted and calculated. | ||
+ | Furthermore different possible linkers were tested, based on dimerization and DNA binding affinity. | ||
+ | </p> | ||
+ | <!--Image Leucine zipper bla blub DryLab | ||
+ | <div class="thumb"> | ||
+ | <div class="thumbinner" style="width:60%;"> | ||
+ | <img alt="" class="thumbimage" | ||
+ | src="" style="width:99%;" /> | ||
+ | <div class="thumbcaption"> | ||
+ | <i><b>Figure 5: DaVinci simulation of GCN4 and rGCN4</b> DaVinci simulation of GCN4 and rGCN4 binding to DNA. | ||
+ | The | ||
+ | simulation was used to predict the binding affinity of the two proteins and to optimize the linker between | ||
+ | them.</i> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | --> | ||
</section> | </section> | ||
− | + | </section> | |
− | </ | + | <section id="5"> |
+ | <h1>5. References</h1> | ||
+ | <p>Fried, M. G. (1989). Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay. | ||
+ | <em>ELECTROPHORESIS, 10</em>(5–6), 366–376. <a href="https://doi.org/10.1002/elps.1150100515" | ||
+ | target="_blank">https://doi.org/10.1002/elps.1150100515</a> | ||
+ | </p> | ||
+ | <p>Hellman, L. M., & Fried, M. G. (2007). Electrophoretic mobility shift assay (EMSA) for detecting | ||
+ | protein-nucleic acid interactions. <em>Nature Protocols, 2</em>(8), 1849–1861. <a | ||
+ | href="https://doi.org/10.1038/nprot.2007.249" target="_blank">https://doi.org/10.1038/nprot.2007.249</a></p> | ||
+ | <p>Hollenbeck, J. J., Gurnon, D. G., Fazio, G. C., Carlson, J. J., & Oakley, M. G. (2001). A GCN4 Variant with a | ||
+ | C-Terminal Basic Region Binds to DNA with Wild-Type Affinity. <em>Biochemistry, 40</em>(46), 13833–13839.</p> | ||
+ | <p>Hollenbeck, J. J., & Oakley, M. G. (2000). GCN4 Binds with High Affinity to DNA Sequences Containing a Single | ||
+ | Consensus Half-Site. <em>Biochemistry, 39</em>(21), 6380–6389. <a href="https://doi.org/10.1021/bi992705n" | ||
+ | target="_blank">https://doi.org/10.1021/bi992705n</a></p> | ||
+ | </section> | ||
+ | |||
</html> | </html> |
Revision as of 23:19, 30 September 2024
Staple subunit: GCN4
GCN4 is a yeast transcription factor belonging to the bZip family of DNA-binding proteins. We use GCN4 to study DNA-binding kinetics in our "Mini staples" that bring two DNA target sites into proximity by binding them simultaneously.
Contents
Next to the well-studied linear DNA sequence, the 3D spatial organization of DNA plays a crucial role in gene
regulation,
cell fate, disease development and more. However, the tools to precisely manipulate this genomic architecture
remain limited, rendering it challenging to explore the full potential of the
3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular
toolbox based on various DNA-binding proteins to address this issue.
The PICasSO part collection offers a comprehensive, modular platform for precise manipulation and re-programming of DNA-DNA interactions using protein staples in living cells, enabling researchers to recreate natural 3D genomic interactions, such as enhancer hijacking, or to design entirely new spatial architectures for gene regulation. Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and testing of new staples, ensuring functionality in vitro and in vivo. We took special care to include parts crucial for testing every step of the cycle (design, build, test, learn) when engineering new parts.
At its heart, the PICasSO part collection consists of three categories.
(i) Our DNA-binding
proteins
include our
finalized enhancer hijacking Cas staple as well as half staples that can be used by scientists to compose entirely
new Cas staples in the future. We also include our Simple staples that serve as controls for successful stapling
and can be further engineered to create alternative, simpler and more compact staples.
(ii) As functional elements, we list additional parts that enhance the functionality of our Cas and
Basic staples. These
consist of
protease-cleavable peptide linkers and inteins that allow condition-specific, dynamic stapling in vivo.
Besides staple functionality, we also include the parts to enable the efficient delivery of PICasSO's constructs
with our
interkingdom conjugation system.
(iii) As the final category of our collection, we provide parts that support the use of our custom
readout
systems. These include components of our established FRET-based proximity assay system, enabling users to
confirm
accurate stapling. Additionally, we offer a complementary, application-oriented testing system for functional
readouts via a luciferase reporter, which allows for straightforward experimental simulation of enhancer hijacking
in mammalian cells.
The following table gives a comprehensive overview of all parts in our PICasSO toolbox. The highlighted parts showed
exceptional performance as described on our iGEM wiki and can serve as a reference. The other parts in
the
collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their
own custom Cas staples, enabling further optimization and innovation.
Our part collection includes:
DNA-binding proteins: The building blocks for engineering of custom staples for DNA-DNA interactions with a modular system ensuring easy assembly. | ||
BBa_K5237000 | fgRNA Entry vector MbCas12a-SpCas9 | Entryvector for simple fgRNA cloning via SapI |
BBa_K5237001 | Staple subunit: dMbCas12a-Nucleoplasmin NLS | Staple subunit that can be combined with sgRNA or fgRNA and dCas9 to form a functional staple |
BBa_K5237002 | Staple subunit: SV40 NLS-dSpCas9-SV40 NLS | Staple subunit that can be combined witha sgRNA or fgRNA and dCas12avto form a functional staple |
BBa_K5237003 | Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS | Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands into close proximity |
BBa_K5237004 | Staple subunit: Oct1-DBD | Staple subunit that can be combined to form a functional staple, for example with TetR. Can also be combined with a fluorescent protein as part of the FRET proximity assay |
BBa_K5237005 | Staple subunit: TetR | Staple subunit that can be combined to form a functional staple, for example with Oct1. Can also be combined with a fluorescent protein as part of the FRET proximity assay |
BBa_K5237006 | Simple staple: TetR-Oct1 | Functional staple that can be used to bring two DNA strands in close proximity |
BBa_K5237007 | Staple subunit: GCN4 | Staple subunit that can be combined to form a functional staple, for example with rGCN4 |
BBa_K5237008 | Staple subunit: rGCN4 | Staple subunit that can be combined to form a functional staple, for example with rGCN4 |
BBa_K5237009 | Mini staple: bGCN4 | Assembled staple with minimal size that can be further engineered | Functional elements: Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization for custom applications |
BBa_K5237010 | Cathepsin B-cleavable Linker: GFLG | Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive staples |
BBa_K5237011 | Cathepsin B Expression Cassette | Expression Cassette for the overexpression of cathepsin B |
BBa_K5237012 | Caged NpuN Intein | A caged NpuN split intein fragment that undergoes protein trans-splicing after protease activation. Can be used to create functionalized staples units |
BBa_K5237013 | Caged NpuC Intein | A caged NpuC split intein fragment that undergoes protein trans-splicing after protease activation. Can be used to create functionalized staples units |
BBa_K5237014 | fgRNA processing casette | Processing casette to produce multiple fgRNAs from one transcript, that can be used for multiplexed 3D genome reprograming |
BBa_K5237015 | Intimin anti-EGFR Nanobody | Interkindom conjugation between bacteria and mammalian cells, as alternative delivery tool for large constructs |
BBa_K4643003 | incP origin of transfer | Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a means of delivery | Readout Systems: FRET and enhancer recruitment to measure proximity of stapled DNA in bacterial and mammalian living cells enabling swift testing and easy development for new systems |
BBa_K5237016 | FRET-Donor: mNeonGreen-Oct1 | FRET Donor-Fluorpohore fused to Oct1-DBD that binds to the Oct1 binding cassette. Can be used to visualize DNA-DNA proximity |
BBa_K5237017 | FRET-Acceptor: TetR-mScarlet-I | Acceptor part for the FRET assay binding the TetR binding cassette. Can be used to visualize DNA-DNA proximity |
BBa_K5237018 | Oct1 Binding Casette | DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET proximity assay |
BBa_K5237019 | TetR Binding Cassette | DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the FRET proximity assay | BBa_K5237020 | Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64 | Readout system that responds to protease activity. It was used to test cathepsin B-cleavable linker |
BBa_K5237021 | NLS-Gal4-VP64 | Trans-activating enhancer, that can be used to simulate enhancer hijacking | BBa_K5237022 | mCherry Expression Cassette: UAS, minimal Promotor, mCherry | Readout system for enhancer binding. It was used to test cathepsin B-cleavable linker |
BBa_K5237023 | Oct1 - 5x UAS binding casette | Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay |
BBa_K5237024 | TRE-minimal promoter- firefly luciferase | Contains Firefly luciferase controlled by a minimal promoter. It was used as a luminescence readout for simulated enhancer hijacking |
1. Sequence overview
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
GCN4 is a yeast transcription factor from the bZip family of DNA-binding proteins, first discovered by McKnight and
co-workers in 1988.
The bZip motif features a coiled-coil leucine zipper dimerization domain paired with a highly charged basic region,
which directly interacts
with DNA. GCN4 binds specifically to the cyclic AMP response element (CRE) DNA sequence (5' ATGACGTCAT 3') in the
promoter regions of target genes, primarily through its basic
residues at the N-terminus.
In our project, GCN4 was employed to study DNA-binding kinetics and develop a minimal "Mini staple" that brings two
DNA target sites into proximity
by binding them simultaneously. This "Mini staple" was designed as a versatile tool for precise DNA manipulation in
synthetic biology applications.
The DNA-binding properties of GCN4 were tested using an electrophoretic mobility shift assay (EMSA) to quantify
binding affinity and kinetics.
EMSA is a widely adopted method to study DNA-protein interactions. It works on the principle that nucleic acids
bound to proteins exhibit reduced
electrophoretic mobility compared to unbound nucleic acids (Hellman & Fried, 2007). EMSA can be employed both
qualitatively, to assess DNA-binding
capabilities, and quantitatively, to determine critical parameters such as binding stoichiometry and the apparent
dissociation constant (Kd)
(Fried, 1989).
The GCN4 amino acid sequence was taken from literature (Hollenbeck et al. 2001) and codon optimized for E.
coli.
A FLAG-tag (DYKDDDDK) was added to the N-terminus for protein purification. The FLAG-tag can be cleaved off using an
Enterokinase, if necessary.
The FLAG-GCN4 sequence was cloned into a T7 expression vector and expressed using E. coli BL21 (DE3) cells.
The FLAG-GCN4 protein could be readily expressed in E. coli BL21 (DE3). The protein was purified using an
anti-FLAG resin.
Fractions taken during purification were analyzed by SDS-PAGE. Purified protein was quantified using a Lowry
assay, 1.18 mg/mL were obtained, resulting in 153 µM of monomeric FLAG-GCN4.
2. Usage and Biology
3. Assembly and part evolution
4. Results
4.1 Protein expression and purification
4.2 Electrophoretic Mobility shift assay
GCN4 was tested for its DNA-binding capabilities using an electrophoretic mobility shift assay (EMSA). The protein
was incubated with a DNA probe containing the GCN4 binding site. The formation of a protein-DNA complex was
analyzed by native PAGE.
To further analyze DNA binding, quantitative shift assays were performed for GCN4 and rGCN4 (BBa_K5237008).
0.5 µM DNA were incubated with varying concentrations of protein until equilibration. After
electrophoresis, bands were stained with SYBR-Safe and quantified based on pixel intensity. The
obtained values were fitted to equation 1, describing formation of a 2:1 protein-DNA complex:
Θapp = Θmin + (Θmax - Θmin) ×
(Ka2 [L]tot2) / (1 + Ka2
[L]tot2)
Equation 1
Here [L]tot describes the total protein monomer concentration, Ka
corresponds
to the apparent monomeric equilibration constant. The Θmin/max values are the
experimentally
determined site saturation values (For this experiment 0 and 1 were chosen for min and max
respectively). GCN4 binds to its optimal DNA binding motif with an apparent dissociation
constant Kk of (0.2930.033)×10-6 M, which is almost identical to the
rGCN4 binding
affinity to INVii a d of (0.2980.030)×10-6 M.
The apparent binding kinetics calculated for GCN4 ((0.2930.033) × 10-6 M) and rGCN4
((0.2980.030) × 10-6 M) are
approximately a factor 10 higher then those described in literature ((96) × 10-8 M for
GCN4 and (2.90.8) × 10-8 M for rGCN4) (Hollenbeck et al., 2001). The
differences could be due to the lower sensitivity of SYBR-Safe staining compared to radio-labeled oligos.
Most likely, the protein concentration was miscalculated due to the presence of additional (lower intensity)
bands in
the SDS-PAGE analysis, indicating the co-purification of small amounts of unspecific proteins.
The FLAG-tag fusion to the N-terminus of proteins could potentially decrease binding affinity, likely due
to steric hindrance affecting the interaction with DNA. Interestingly, the differences in binding affinity
between GCN4 and rGCN4 appear negligible. Since GCN4 binds to DNA via its N-terminus and rGCN4 binds
C-terminally, the FLAG-tag likely does not directly influence DNA binding. However, it may influence the
dimerization of the proteins, which is necessary for DNA binding. To further investigate this, the
FLAG-tag can be cleaved using an enterokinase and potential changes in binding affinity analyzed
4.3 In Silico Characterization using DaVinci
We developed the in silico model DaVinci for rapid engineering and development of our PiCasSO system. DaVinci acts as a digital twin to PiCasSO, designed to understand the forces acting on our system, refine experimental parameters, and find optimal connections between protein staples and target DNA. We calibrated DaVinci with literature and our own experimental affinity data obtained via EMSA assays and purified proteins. This enabled us to simulate enhancer hijacking in silico, providing valuable input for the design of further experiments. Additionally, we apply the same approach to our part collection. DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged dna dynamics simulation. We applied the first two to our parts, characterizing structure and dynamics of the dna-binding interaction.
In our efforts to create a bivalent DNA binding protein with minimal size, we designed a Mini staple consisting of GCN4 fused with an GSG-linker to rGCN4. The structure and binding affinity of GCN4 were predicted and calculated. Furthermore different possible linkers were tested, based on dimerization and DNA binding affinity.
5. References
Fried, M. G. (1989). Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay. ELECTROPHORESIS, 10(5–6), 366–376. https://doi.org/10.1002/elps.1150100515
Hellman, L. M., & Fried, M. G. (2007). Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. Nature Protocols, 2(8), 1849–1861. https://doi.org/10.1038/nprot.2007.249
Hollenbeck, J. J., Gurnon, D. G., Fazio, G. C., Carlson, J. J., & Oakley, M. G. (2001). A GCN4 Variant with a C-Terminal Basic Region Binds to DNA with Wild-Type Affinity. Biochemistry, 40(46), 13833–13839.
Hollenbeck, J. J., & Oakley, M. G. (2000). GCN4 Binds with High Affinity to DNA Sequences Containing a Single Consensus Half-Site. Biochemistry, 39(21), 6380–6389. https://doi.org/10.1021/bi992705n